Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

Hansoh Pharma shares head skyward after HKEX debut

Hansoh Pharma shares head skyward after HKEX debut

Since its inception it has become a major producer of generic cancer and central nervous system drugs for China’s domestic market, and has also brought two Category 1.1 innovative ... drugs through to registration, including a once-weekly pegylated

Latest news

  • Syncona launches another cell therapy company, Treg specialist Quell Syncona launches another cell therapy company, Treg specialist Quell

    such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease, and graft-versus-host disease (GvHD). ... Still going it alone are companies like Caladrius Biosciences, with a cell-based Treg-based treatment called CLBS03 for type 1 diabetes

  • Genentech forges $800m autoimmune alliance with Parvus Genentech forges $800m autoimmune alliance with Parvus

    It’s not the first licensing deal for the Canadian biotech, which is also working with Novartis on a type 1 diabetes programme agreed in 2017, but is on a much ... Under the terms of the agreement with Genentech, privately-held Parvus will carry out

  • NICE recommends MSD’s diabetes drug Steglatro NICE recommends MSD’s diabetes drug Steglatro

    NICE has cleared MSD’s type 2 diabetes treatment Steglatro for routine NHS use in combination with metformin, or as a monotherapy for those who are intolerant to the anti-diabetic ... Forxiga recently expanded its use in type 1 diabetes in the EU in

  • Success for AZ, setback for Sanofi in type 1 diabetes Success for AZ, setback for Sanofi in type 1 diabetes

    Forxiga approved as add-on to insulin. AstraZeneca has won EU approval for the first oral add-on to insulin in type 1 diabetes, just as Sanofi’s attempt to match ... The approval means AZ’s SGLT2 inhibitor Forxiga (dapagliflozin) can be used in the

  • Pfizer closes on EU approval of lung cancer drug Vizimpro Pfizer closes on EU approval of lung cancer drug Vizimpro

    AZ claims first with Forxiga in type 1 diabetes. Among the usual crop of line extensions, AZ’s SGLT2 inhibitor Forxiga (dapagliflozin) became the first oral add-on treatment to insulin ... for treatment of certain patients with type 1 diabetes, adding

More from news
Approximately 7 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    The most heartfelt category of the evening was undoubtedly The People’s Award, which was presented to Beth Baldwin, who lost her son at age 13 to undiagnosed type 1 diabetes ... type 1 diabetes.

  • No incentive for a cure No incentive for a cure

    The paradox of ‘cost-effective but unaffordable’ life-saving medicines. Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to

  • The rise of real-world evidence The rise of real-world evidence

    Diabeter, a Dutch chain of type 1 diabetes clinics bought by Medtronic in 2015, is an example of this trend. ... and then have it come through a pipe so it populates our practice management system,” Sue Willman, vice president of global diabetes

  • Taking a lean and careful approach Taking a lean and careful approach

    ulcerative colitis, type 1 diabetes and inflammatory bowel disease. ... This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels.

  • Strategic planning in the digital age Strategic planning in the digital age

    In the type 1 diabetes therapy area, healthcare professionals in the UK alone published more than 50, 000 posts on public social media discussing the disease during 2016. ... A study by CREATION of healthcare professional needs in type 1 diabetes,

More from intelligence
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest appointments

  • JDRF names new CEO JDRF names new CEO

    Derek Rapp to lead diabetes research charity. The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mixing up Focus Groups

    Let’s consider a person with Type 1 diabetes, for a moment. ... Wouldn’t that provide a rich, true and insightful understanding of the real world where diabetes is concerned?

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Including a case study showing the perspective of a young person newly diagnosed with type 1 diabetes. ... and Turner, H.M., 2005. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes.

  • Attigo (part of the Mednet Group)

    For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. ... Including a case study showing the perspective of a young person newly

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to

  • How technology is shaping patient education

    The relative simplicity of producing an app has been demonstrated by a recent study by Bournemouth University showing how people with type 1 diabetes can participate effectively in the design of ... 10] Pulman, A., Hill, J. and Masding, M. G., 2013. The

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics